The majority of patients with NCL2 (classic late infantile-onset form) develop eye symptoms towards the end of the illness, typically at four to five years old. Around the ages of two to three, the kid starts to experience speech delays and epilepsy; by the time they are five, ataxia and global developmental delay may also be present. This evidence concerns the gene CAPN8 and cerebellar ataxia.